Bizarre Patents
Method and apparatus for making a drink hop along a bar or counter
A method for generating a drink which appears to hop from a remote spot on the bar or counter and take one or more leaps, before landing in a patron's glass.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8080640 | Recombinant transferrins, transferrin half-molecules and mutants thereof Recombinant transferrin, non-glycosylated recombinant transferrin, transferrin half-molecules and mutant transferrins having altered metal-binding or other properties are described. The recombinant transferrin molecules are expressed in functional form by stable euk... | 12/20/2011 |
| 7365173 | Method for the production of pure virally inactivated butyrylcholinesterase The present invention provides a method for purifying butyrylcholinesterase from various biological fluids. Biological fluids include, e.g., blood, blood fractions, plasma, and bioreactor broths, and other such mixtures containing butyrylcholinesterase. In one embod... | 04/29/2008 |
| 7285646 | Ultrapure transferrin for pharmaceutical compositions The present invention relates to an ultrapure human transferrin, and to methods for manufacturing the ultrapure transferrin. The transferrin may be holo-, apo- or at any desired degree of iron saturation. The invention further relates to the use of ultrapure transfe... | 10/23/2007 |
| 7176278 | Modified transferrin fusion proteins The present invention discloses fusion proteins comprising transferrin, lactoferrin or melanotransferrin fused to glucagon-like peptide 1 (GLP-1). In one embodiment of the invention, the fusion protein displays increased serum half-life as compared to a GLP-1 peptid... | 02/13/2007 |
| 7138520 | Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same In part, the present invention is directed to coordination complexes comprising a therapeutic agent. In one aspect, the subject compositions comprise a platinum metal center and a covalently attached therapeutic agent. ... | 11/21/2006 |
| 7101842 | Targeted delivery of drugs for the treatment of parasitic infections Targeting agents such as transferrin and transcobalamin can be conjugated with anti-protozoan drugs for the treatment of protozoan infections. Any suitable anti-protozoan drug can be used, preferably the drug is selected from the group consisting of apoptosis induci... | 09/05/2006 |
| 7053185 | Lactalbumin production process A method for producing an oligomeric form of α-lactalbumin which is in the molten globule-like state is described. The method suitably comprises exposing a source of α-lactalbumin in which the α-lactalbumin is preferably in the molten globule-like state, to an io... | 05/30/2006 |
| 7030088 | Human secreted hemopexin-related proteins The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the secreted peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of ide... | 04/18/2006 |
| 7001991 | Targeted delivery of bioaffecting compounds for the treatment of cancer A homogeneous conjugate for targeting and treating diseased cells wherein the conjugate comprises an anti-cancer drug and a targeting protein, wherein said anti-cancer drug is selected from the group consisting of heat sensitizers, photosensitizers and apoptosis ind... | 02/21/2006 |
| 6881828 | Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin A hybrid fusion protein comprising a first antigenic amino acid sequence fused to a second amino acid sequence substantially homologous to B2M or a fragment thereof. ... | 04/19/2005 |
| 6825037 | Recombinant transferrins, transferrin half-molecules and mutants thereof Recombinant transferrin, non-glycosylated recombinant transferrin, transferrin half-molecules and mutant transferrins having altered metal-binding or other properties are described. The recombinant transferrin molecules are expressed in functional form by stable euk... | 11/30/2004 |
| 6328966 | Transferrin compositions to alleviate the side effects of cytotoxic drugs The invention pertains to eutrophic drug composition containing transferrins, particularly human transferrins. This composition allows the toxic effects of cytotoxic drugs such as cyclosporin when used at high dosages or over a prolonged period of time to... | 12/11/2001 |
| 6326473 | Pharmaceutical preparations The present invention relates to pharmaceutical compositions of transferrin and to the manufacture of such preparations. The present invention concerns specifically a pharmaceutical composition of apotransferrin, the iron-free form of transferrin, wherein... | 12/04/2001 |
| 6319498 | Modulators of amyloid aggregation Compounds that modulate the aggregation of amyloidogenic proteins or peptides are disclosed. The modulators of the invention can promote amyloid aggregation or, more preferably, can inhibit natural amyloid aggregation. In a preferred embodiment, the compo... | 11/20/2001 |
| 6251860 | Pharmaceutical preparations The present invention relates to pharmaceutical compositions of transferrin and to the manufacture of such preparations. The present invention concerns specifically a pharmaceutical composition of apotransferrin, the iron-free form of transferrin, wherein... | 06/26/2001 |
| 6153408 | Altered major histocompatibility complex (MHC) determinant and methods of using the determinant An altered MHC class I determinant comprises 댑, 댒, 댓, 댢 -microglobulin (댢 m) polypeptide domains encoded by a mammalian MHC class I locus in which the 댓 | 11/28/2000 |
| 6096870 | Sequential separation of whey The present invention is related to the separation of whey proteins, particularly the sequential separation of whey proteins into separate fractions through the use of chromatography. The present invention further provides methods and compositions for the... | 08/01/2000 |
| 5986063 | Isolating ଲ-lactoglobulin and -lactalbumin by eluting from a cation exchanger without sodium chloride A method is provided for isolating the proteins, ଲ-lactoglobulin and -lactalbumin, from whey with a single cation exchanger, and using different pH values for eluting the proteins as separate fractions without using salt elution. A whey prote... | 11/16/1999 |
| 5986067 | Recombinant transferrins, transferrin half-molecules and mutants thereof Recombinant transferrin, non-glycosylated recombinant transferrin, transferrin half-molecules and mutant transferrins having altered metal-binding or other properties are described. The recombinant transferrin molecules are expressed in functional form by... | 11/16/1999 |
| 5985275 | ଲ-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection A composition is provided which comprises a protein or peptide containing lysines, wherein at least one of the lysines and/or the N-terminal amino group of the protein or peptide, such as casein, ଲ-lactoglobulin, powdered milk or whey, is modified b... | 11/16/1999 |
| 5914312 | Pretargeting methods and compounds Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin and for improved radiohalogenation of biotin, as well as related com... | 06/22/1999 |
| 5833988 | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates The present invention pertains to a method for delivering a neuropharmaceutical or diagnostic agent across the blood brain barrier to the brain of a host. The method comprises administering to the host a therapeutically effective amount of an antibody-neu... | 11/10/1998 |
| 5827737 | In vitro activation of cytotoxic T cells The present invention relates to a rational, elegant means of producing, loading and using Class I molecules to specifically activate CD8 cells in vitro, and their therapeutic applications in the treatment of a variety of conditions, including cancer, tum... | 10/27/1998 |
| 5817765 | Purification of plasma proteins Virus inactivating chemicals and/or detergents in an aqueous composition containing a water-soluble plasma protein are reduced by selecting a suitable combination of temperature and concentration above 0.5M of salt with a high salting out effect according... | 10/06/1998 |
| 5756680 | Sequential separation of whey proteins and formulations thereof A method is disclosed for the sequential separation of whey proteins using radial-flow chromatography. Different buffer systems adjusted to suitable pH and ionic strength are utilized in the separation process. The method separates at least five different... | 05/26/1998 |
| 5744586 | Manufacturing process for the production of purified transferrin Method for obtaining highly purified transferrin from a partially purified plasma fraction containing transferrin in which the starting fraction is concentrated. Its ionic strength is reduced and then transferrin is adsorbed onto a chromatographic column.... | 04/28/1998 |
| 5728383 | Treatment of tumors of the central nervous system with immunotoxins Potent and specific immunotoxins are prepared by conjugation of moieties binding to receptors on the surface of tumor cells to a mutant diphtheria toxin having A-chain translocation activity, but lacking membrane-binding activity. The immunotoxins are use... | 03/17/1998 |
| 5679780 | Method for obtaining high-quality protein products from whey High quality protein products are obtained from whey by subjecting whey to cross flow filtration in microfilter. The whey and retentate are brought to circulate in a circulation path on one side of the membrane area of the microfilter, while whey which ha... | 10/21/1997 |
| 5648469 | Monoclonal antibodies reactive with transferrin receptor cytoplasmic domain Monoclonal antibodies have been produced which specifically bind to epitopes found in the cytoplasmic domain of the transferrin receptor (TR). The antibodies are useful for isolating sequences in a sample which contain TR cytoplasmic domain.... | 07/15/1997 |
| 5606086 | Iron lactoferrin complexes and preparation thereof Heat resistant carbonate- and/or hydrogencarbonate-iron-Lf complexes in which one molecule of lactoferrin is bound with 15 molecules or over of iron via carbonic acid and/or hydrogencarbonic acid. Process for the production of above mentioned complexes prepare... | 02/25/1997 |
| 5576299 | Formulated medicine for treatment and prevention of opportunistic infectious diseases complicated by infection with lentivirus The protein lactoferrin can be used both for treating and/or preventing of portunistic infections frequently complicating Immunodeficiency Virus positive animals including human beings. The protein greatly improves the quality of life in such immunodefici... | 11/19/1996 |
| 5442043 | Peptide conjugate The present invention provides a conjugate capable of passing the blood-brain barrier comprising a bioactive peptide or protein incapable of passing the blood-brain barrier and a carrier peptide which exhibits substantially no bioactivity and which is cap... | 08/15/1995 |
| 5393737 | Cytotoxic drug conjugates for treatment of neoplastic diseases A novel composition of matter comprising a ligand-carbohydrate-cytotoxic drug conjugate is produced by the steps of (1) reacting a carbohydrate with a ligand, (2) reacting the product of step (1) with a cytotoxic drug, and (3) stabilizing the product of s... | 02/28/1995 |
| 5352447 | Immunotoxins for treatment of intracranial lesions and as adjunct to chemotherapy A potent and specific immunotoxin is prepared by coupling a binding-site inactivated diphtheria toxin (CRM 107) to a new binding moiety consisting of transferrin or a monoclonal antibody against the human transferrin receptor. These immunotoxins are tumor... | 10/04/1994 |
| 5292869 | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same The present invention relates to a method for isolating and purifying transferrin and lactoferrin receptor proteins from bacterial pathogens by affinity chromatography and to the preparation of vaccine antigens containing the purified receptor proteins.... | 03/08/1994 |
| 5256412 | Anti-HIV agent The invention relates to an anti-HIV agent comprising as an effective component a plasma protein of which the polarity of the amino group of the amino acid residue constituting the plasma protein is chemically modified into a negative moiety by a carboxyl... | 10/26/1993 |
| 5252715 | Process for the preparation of a pasteurized and iron-free human transferrin and the use thereof A process for the preparation of an iron-free, pasteurized human transferrin is described and entails human transferrin being pasteurized in the presence of a complexing agent in solution, and the complexing agent being removed with the bound iron. This t... | 10/12/1993 |
| 5208323 | Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent The present invention relates to antitumor compounds of the formula I: ##STR1## wherein M is selected from the group consisting of an hydrogen atom, a peptide residue, and a protein residue linked to the carbon atom via the amino residue of &3xb5;-ly... | 05/04/1993 |
| 5208021 | Method of preparing diphtheria immunotoxins A potent and specific immunotoxin is prepared by coupling an inactivated diphteria toxin to a binding moiety such as a monoclonal antibody or transferrin. The immunotoxins are specific for human tumors and leukemias and are indistinguishable in cell toxic... | 05/04/1993 |
| 5164486 | Method of inhibiting large cell formation The invention relates to an anti-HIV agent comprising as an effective component a plasma protein of which the polarity of the amino group of the amino acid residue constituting the plasma protein is chemically modified into a negative moiety by a carboxyl... | 11/17/1992 |
